ELF5-Regulated lncRNA-TTN-AS1 Alleviates Myocardial Cell Injury via Recruiting PCBP2 to Increase CDK6 Stability in Myocardial Infarction

References

• Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau J-L, Solomon SD, et al. Angiotensin receptor-neprilysin inhibition in acute myocardial infarction. N Engl J Med. 2021;385:1845–1855. doi:10.1056/NEJMoa2104508.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, et al. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999;34:1403–1412. doi:10.1016/s0735-1097(99)00397-6.
   PubMed Web of Science ®Google Scholar
• Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165768. doi:10.1016/j.bbadis.2020.165768.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100. doi:10.1172/JCI62874.
   PubMed Web of Science ®Google Scholar
• Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220:e202009045. doi:10.1083/jcb.202009045.
   PubMed Web of Science ®Google Scholar
• Azat M, Huojiahemaiti X, Gao R, Peng P. Long noncoding RNA MIAT: a potential role in the diagnosis and mediation of acute myocardial infarction. Mol Med Rep. 2019;20:5216–5222. doi:10.3892/mmr.2019.10768.
   PubMed Web of Science ®Google Scholar
• Wang Y-W, Dong H-Z, Tan Y-X, Bao X, Su Y-M, Li X, Jiang F, Liang J, Huang Z-C, Ren Y-L, et al. HIF-1α-regulated lncRNA-TUG1 promotes mitochondrial dysfunction and pyroptosis by directly binding to FUS in myocardial infarction. Cell Death Discov. 2022;8:178. doi:10.1038/s41420-022-00969-8.
   PubMed Web of Science ®Google Scholar
• Lin G, Liu X, Cong C, Xu LJ. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies. Cancer Rep (Hoboken). 2023;6:e1876. doi:10.1002/cnr2.1876.
   PubMedGoogle Scholar
• Jia L, Wang W, Liu H, Zhu F, H, Yunfang. LncRNA TTN-AS1 exacerbates extracellular matrix accumulation via miR-493-3p/FOXP2 axis in diabetic nephropathy. J Genet. 2023;102:11.
   PubMed Web of Science ®Google Scholar
• Pei X, Wu Y, Yu H, Li Y, Zhou X, Lei Y, Lu W. Protective role of lncRNA TTN-AS1 in sepsis-induced myocardial injury via miR-29a/E2F2 axis. Cardiovasc Drugs Ther. 2022;36:399–412. doi:10.1007/s10557-021-07244-5.
   PubMed Web of Science ®Google Scholar
• Foletta VC. Transcription factor AP-1, and the role of Fra-2. Immunol Cell Biol. 1996;74:121–133. doi:10.1038/icb.1996.17.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu J, Xia S-W, Zhao F, Ding Q, Ye X-M, Zhong J-F, Chen K-L, Wang H-L. miR-27a-3p relieves heat stress-induced mitochondrial damage and aberrant milk protein synthesis through MEK/ERK pathway in BMECs. Cell Stress Chaperones. 2023;28:265–274. doi:10.1007/s12192-023-01334-z.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H-L, Lin Z-P, Zhong J-F, Chen K-L, Duan X. Depletion of serum-derived exosomes aggravates heat stress-induced damage of bovine mammary epithelial cells. Mol Biol Rep. 2022;49:9297–9305. doi:10.1007/s11033-022-07767-6.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen L, Feng Z, Chen W, Yan S, Yang R, Xiao J, Gao J, Zhang D, Ke X, et al. EPC-derived exosomal miR-1246 and miR-1290 regulate phenotypic changes of fibroblasts to endothelial cells to exert protective effects on myocardial infarction by targeting ELF5 and SP1. Front Cell Dev Biol. 2021;9:647763. doi:10.3389/fcell.2021.647763.
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Komiya M, Matsumura K, Negishi L, Suda S, Okuno M, Yokota N, Osada T, Nagashima T, Hiyoshi M, et al. MYU, a target lncRNA for Wnt/c-Myc signaling, mediates induction of CDK6 to promote cell cycle progression. Cell Rep. 2016;16:2554–2564. doi:10.1016/j.celrep.2016.08.015.
   PubMed Web of Science ®Google Scholar
• Piezzo M, Cocco S, Caputo R, Cianniello D, Gioia GD, Lauro VD, Fusco G, Martinelli C, Nuzzo F, Pensabene M, et al. Targeting cell cycle in breast cancer: CDK4/6 inhibitors. Int J Mol Sci. 2020;21:21. doi:10.3390/ijms21186479.
   Google Scholar
• Li Y, Sun G, Wang L. MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6. Inflamm Res. 2022;71:205–214. doi:10.1007/s00011-021-01535-1.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tian C, Liu X, Zhang H. Identification of genetic biomarkers for diagnosis of myocardial infarction compared with angina patients. Cardiovasc Ther. 2020;2020:8535314. doi:10.1155/2020/8535314.
   PubMed Web of Science ®Google Scholar
• Yabe-Wada T, Philpott CC, Onai N. PCBP2 post-transcriptionally regulates sortilin expression by binding to a C-rich element in its 3' UTR. FEBS Open Bio. 2020;10:407–413. doi:10.1002/2211-5463.12794.
   PubMed Web of Science ®Google Scholar
• Wen D, Huang Z, Li Z, Tang X, Wen X, Liu J, Li M. LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA. J Cell Physiol. 2020;235:7592–7603. doi:10.1002/jcp.29667.
   PubMed Web of Science ®Google Scholar
• Krittanawong C, Khawaja M, Tamis-Holland JE, Girotra S, Rao SV. Acute myocardial infarction: etiologies and mimickers in young patients. J Am Heart Assoc. 2023;12:e029971. doi:10.1161/JAHA.123.029971.
   PubMedGoogle Scholar
• Arif M, Klevstig M, Benfeitas R, Doran S, Turkez H, Uhlén M, Clausen M, Wikström J, Etal D, Zhang C, et al. Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction. eLlife. 2021;10:e66921. doi:10.7554/eLife.66921.
   PubMed Web of Science ®Google Scholar
• Shiraishi M, Yamaguchi A, Suzuki K. Nrg1/ErbB signaling-mediated regulation of fibrosis after myocardial infarction. FASEB J. 2022;36:e22150. doi:10.1096/fj.202101428RR.
   PubMed Web of Science ®Google Scholar
• Adapala RK, Kanugula AK, Paruchuri S, Chilian WM, Thodeti CK. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation. Basic Res Cardiol. 2020;115:14. doi:10.1007/s00395-020-0775-5.
   PubMed Web of Science ®Google Scholar
• Yan H, Qiu L, Xie X, Yang H, Liu Y, Lin X, Huang H. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells. Oncol Rep. 2017;37:1412–1418. doi:10.3892/or.2017.5418.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lin J, Ma Y, Zhao J. Overexpression of E74-Like Factor 5 (ELF5) inhibits migration and invasion of ovarian cancer cells. Med Sci Monit. 2019;25:856–865. doi:10.12659/MSM.913058.
   PubMed Web of Science ®Google Scholar
• Luo JF, Xu J, Zheng JZ. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p. Eur Rev Med Pharmacol Sci. 2019;23:7816–7825. doi:10.26355/eurrev_201909_18991.
   PubMedGoogle Scholar
• Feng Q, Hu K, Hu H, Lu Y, Zhang H, Wang G, Zhang Q, Xu Z, Gao X, Jia X, et al. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells. Int Immunopharmacol. 2023;125:111139. doi:10.1016/j.intimp.2023.111139.
   PubMed Web of Science ®Google Scholar
• Tian C, Yang Y, Ke Y, Yang L, Zhong L, Wang Z, Huang H. Integrative analyses of genes associated with right ventricular cardiomyopathy induced by tricuspid regurgitation. Front Genet. 2021;12:708275. doi:10.3389/fgene.2021.708275.
   PubMed Web of Science ®Google Scholar
• Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, et al. Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor. Cancer Cell. 2021;39:1404–1421.e11. doi:10.1016/j.ccell.2021.08.009.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhou L, Yang T, Deng B, Bao Y, Gu L, Wang H, Wang L. P16(INK4a) regulates ROS-related autophagy and CDK4/6-mediated proliferation: a new target of myocardial regeneration therapy. Oxid Med Cell Longev. 2023;2023:1696190. doi:10.1155/2023/1696190.
   PubMedGoogle Scholar
• Li B, Wang Z, Yang F, Huang J, Hu X, Deng S, Tian M, Si X. miR449a5p suppresses CDK6 expression to inhibit cardiomyocyte proliferation. Mol Med Rep. 2021;23:14. doi:10.3892/mmr.2020.11652.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhou L, Yang T, Deng B, Bao Y, Gu L, et al. P16 regulates ROS-related autophagy and CDK4/6-mediated proliferation: a new target of myocardial regeneration therapy. Oxid Med Cell Longevity. 2023;2023:1696190.
   PubMedGoogle Scholar
• Zhang L, Zhang L, Guo F. MiRNA-494-3p regulates bupivacaine-induced neurotoxicity by the CDK6-PI3K/AKT signaling. Neurotox Res. 2021;39:2007–2017. doi:10.1007/s12640-021-00427-w.
   PubMed Web of Science ®Google Scholar
• Ataei-Nazari S, Amoushahi M, Madsen JF, Jensen J, Heuck A, Mohammadi-Sangcheshmeh A, Lykke-Hartmann K. Cyclin-dependent kinase 6 (CDK6) as a potent regulator of the ovarian primordial-to-primary follicle transition. Front Cell Dev Biol. 2022;10:1036917. doi:10.3389/fcell.2022.1036917.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Marzook H, Gupta A, Aref A, Patil K, Khan AA, Saleh MA, Koch WJ, Woodgett JR, Qaisar R, et al. GSK-3α aggravates inflammation, metabolic derangement, and cardiac injury post-ischemia/reperfusion. J Mol Med (Berl). 2023;101:1379–1396. doi:10.1007/s00109-023-02373-w.
   PubMed Web of Science ®Google Scholar
• Khan K, Makhoul G, Yu B, Schwertani A, Cecere R. The cytoprotective impact of yes-associated protein 1 after ischemia-reperfusion injury in AC16 human cardiomyocytes. Exp Biol Med (Maywood). 2019;244:802–812. doi:10.1177/1535370219851243.
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Cao S, Zhou G, Jiang Y, Feng J. Circ-SUZ12 protects cardiomyocytes from hypoxia-induced dysfunction through upregulating SUZ12 expression to activate Wnt/β-catenin signaling pathway. Int Heart J. 2023;64:1113–1124. doi:10.1536/ihj.22-452.
   PubMed Web of Science ®Google Scholar